Edgewise Therapeutics - A Movement in Muscle
Jan 13, 2025 · At Edgewise, we’re bringing our unique expertise and singular focus on muscle science to develop novel therapeutics for serious skeletal and cardiac muscle diseases – with determination, integrity and a strong commitment to patients.
Edgewise Therapeutics Strengthens Leadership Team to Support …
1 day ago · Edgewise Therapeutics is a leading muscle disease biopharmaceutical company developing novel therapeutics for muscular dystrophies and serious cardiac conditions. The Company’s deep expertise in muscle physiology is driving a new generation of novel therapeutics. Sevasemten is an orally administered first-in-class fast skeletal myosin ...
Cautious Hold Rating for Edgewise Therapeutics Amid Uncertain ...
3 days ago · Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of innovative treatments for severe, rare muscle disorders.
Edgewise Therapeutics, Inc. (EWTX) - Yahoo Finance
Edgewise Therapeutics, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapies for the treatment of muscle disorders.
Edgewise Therapeutics Announces Positive Top-Line Data from …
Sep 19, 2024 · EDG-7500 is a novel oral, selective, cardiac sarcomere modulator, specifically designed to slow early contraction velocity and address impaired cardiac relaxation associated with HCM. In the...
Edgewise Therapeutics, Inc. - Investor Relations
Edgewise Therapeutics is a leading muscle disease biopharmaceutical company developing novel therapeutics for muscular dystrophies and serious cardiac conditions. Guided by our approach to targeting the muscle as an organ, we have combined our foundational expertise in muscle biology and small molecule drug discovery to build our proprietary ...
Precision Therapeutics for Serious Muscle Diseases
Learn more about how our science is driving a new understanding of muscle and its potential to transform human health. See our pipeline of the novel precision therapeutics for serious muscle diseases in development.
About Edgewise Therapeutics
At Edgewise, we appreciate the life-limiting impact of serious muscle diseases. We are committed to helping people and families living with them by pursuing a new era of muscle-focused medicines with patients at the center. That’s why we built Edgewise differently.
Edgewise Therapeutics Reports Third Quarter 2024 Financial …
BOULDER, Colo., November 07, 2024 -- (BUSINESS WIRE)--Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today reported financial results for the...
Edgewise Therapeutics Inc (EWTX) Stock Price & News - Google
Get the latest Edgewise Therapeutics Inc (EWTX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
- Some results have been removed